Search

everythinglearnresearchcommunity

for

Search:↓

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Some women with PCOS have rare genetic variants linked to the condition.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Targeting the p63 gene could help treat skin diseases.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Stem cells have great potential for treating various medical conditions.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

PRP shows promise but lacks consistent evidence and regulation.

Exosomes could be key in treating skin conditions and healing wounds.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Water extract of Cacumen Platycladi helps hair growth by activating specific cell pathways.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Myotonic dystrophy may be classified as a segmental progeroid disorder.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Understanding sex and gender differences can improve personalized dermatology care.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Melatonin helps reduce aging signs in human eyelid skin.